Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

[Economic analysis of a screening program for diabetes mellitus in Brazil].

Georg AE, Duncan BB, Toscano CM, Schmidt MI, Mengue S, Duarte C, Polanczyk CA; Grupo de Trabalho de Avaliação da Campanha Nacional de Detecção de Diabetes Mellitus.

Rev Saude Publica. 2005 Jun;39(3):452-60. Epub 2005 Jun 30. Portuguese.

2.

Initial impact and cost of a nationwide population screening campaign for diabetes in Brazil: a follow up study.

Toscano CM, Duncan BB, Mengue SS, Polanczyk CA, Nucci LB, Costa e Forti A, Fonseca CD, Schmidt MI; CNDDM Working Group.

BMC Health Serv Res. 2008 Sep 22;8:189. doi: 10.1186/1472-6963-8-189.

3.

Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis.

Zhang P, Engelgau MM, Valdez R, Cadwell B, Benjamin SM, Narayan KM.

Diabetes Care. 2005 Jun;28(6):1321-5.

PMID:
15920046
4.

Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus.

Kim C, Herman WH, Vijan S.

Diabetes Care. 2007 May;30(5):1102-6. Epub 2007 Feb 23.

PMID:
17322480
5.

Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study.

Zhang Y, Sun J, Pang Z, Gao W, Sintonen H, Kapur A, Qiao Q.

Prim Care Diabetes. 2013 Dec;7(4):275-82. doi: 10.1016/j.pcd.2013.08.003. Epub 2013 Sep 8.

PMID:
24021478
6.

A nationwide population screening program for diabetes in Brazil.

Nucci LB, Toscano CM, Maia AL, Fonseca CD, Britto MM, Duncan BB, Schmidt MI; Brazilian National Campaign for Diabetes Mellitus Detection Working Group.

Rev Panam Salud Publica. 2004 Nov;16(5):320-7.

PMID:
15729981
7.

Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies.

Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM.

Diabetes Care. 2003 Sep;26(9):2536-42.

PMID:
12941715
8.

Outcome and cost of a statewide diabetes screening and awareness initiative in New York.

Hosler AS, Berberian EL, Spence MM, Hoffman DP.

J Public Health Manag Pract. 2005 Jan-Feb;11(1):59-64.

PMID:
15692294
9.

Community-based screening for diabetes in Michigan.

Tabaei BP, Burke R, Constance A, Hare J, May-Aldrich G, Parker SA, Scott A, Stys A, Chickering J, Herman WH.

Diabetes Care. 2003 Mar;26(3):668-70.

PMID:
12610019
10.

Combined use of fasting plasma glucose and glycated hemoglobin A1c in a stepwise fashion to detect undiagnosed diabetes mellitus.

Nakagami T, Tominaga M, Nishimura R, Daimon M, Oizumi T, Yoshiike N, Tajima N.

Tohoku J Exp Med. 2007 Sep;213(1):25-32.

11.

Community screening for diabetes. Low detection rate in a low-risk population.

Newman WP, Nelson R, Scheer K.

Diabetes Care. 1994 May;17(5):363-5.

PMID:
8062600
12.

[What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].

Ryu S, Chang YS, Kim DI, Suh BS, Kim WS.

J Prev Med Public Health. 2005 May;38(2):203-7. Korean.

13.

Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).

Hauner H, Hanisch J, Bramlage P, Steinhagen-Thiessen E, Schunkert H, Jöckel KH, Wasem J, Moebus S.

Exp Clin Endocrinol Diabetes. 2008 Jan;116(1):18-25. Epub 2007 Oct 9.

PMID:
17926235
14.

Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: target populations for efficient screening.

Bando Y, Kanehara H, Aoki K, Katoh K, Toya D, Tanaka N.

Diabetes Res Clin Pract. 2009 Mar;83(3):341-6. doi: 10.1016/j.diabres.2008.11.033. Epub 2008 Dec 31.

PMID:
19118911
15.

Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.

Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN.

Diabetes Care. 2007 May;30(5):1120-4. Epub 2007 Mar 2.

PMID:
17337498
16.

Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods.

van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J.

J Clin Psychiatry. 2006 Oct;67(10):1493-500.

PMID:
17107239
17.
18.

Point-of-care testing as a tool for screening for diabetes and pre-diabetes.

Rush E, Crook N, Simmons D.

Diabet Med. 2008 Sep;25(9):1070-5. doi: 10.1111/j.1464-5491.2008.02526.x.

PMID:
19183312
19.

Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.

Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr.

Acad Emerg Med. 2008 Dec;15(12):1241-7. doi: 10.1111/j.1553-2712.2008.00240.x. Epub 2008 Sep 8.

20.

Cost-effectiveness of type 2 diabetes screening: results from recently published studies.

Icks A, Rathmann W, Haastert B, John J, Löwel H, Holle R, Giani G; KORA Study Group.

Gesundheitswesen. 2005 Aug;67 Suppl 1:S167-71.

PMID:
16032536

Supplemental Content

Support Center